Biomarkers in community-acquired pneumonia (CAP)

R. Hasa, A. Bulo, P. Kapisyzi, H. Hafizi, S. Bala, R. Hasa, D. Argjiri, M. Nanushi, J. Nikolla, O. Petre, A. Shehu, E. Petrela, J. Bushati (Tirana, Albania)

Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Session: Respiratory infections: a clinical point of view
Session type: Thematic Poster Session
Number: 569
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Hasa, A. Bulo, P. Kapisyzi, H. Hafizi, S. Bala, R. Hasa, D. Argjiri, M. Nanushi, J. Nikolla, O. Petre, A. Shehu, E. Petrela, J. Bushati (Tirana, Albania). Biomarkers in community-acquired pneumonia (CAP). Eur Respir J 2012; 40: Suppl. 56, 569

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012


Epidemiology of community-acquired pneumonia (CAP)
Source: International Congress 2015 – Russia Day: Community-acquired pneumonia (CAP) in adults
Year: 2015



Atypical agents of community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 485s
Year: 2003

Biomarkers and community-adquired pneumonia (CAP) etiology
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012


Role of virus in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012

Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011


Biomarkers in community-acquired pneumonia: still searching for the one
Source: Eur Respir J, 53 (2) 1802469; 10.1183/13993003.02469-2018
Year: 2019



Use of ceftriaxone/sulbactame for treatment of mild-to-severe community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009

Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Community-acquired pneumonia (CAP) and pregnancy
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Corticosteroids and community-acquired pneumonia
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007


Validation of pneumonia severity models for healthcare-associated pneumonia (HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

Community-acquired pneumonia
Source: Respipedia Article
Year: 2017

Are there radiographic differences between patients with community-acquired (CAP) and healthcare-associated pneumonias (HCAP)?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Applicability of Fine criteria in patients hospitalized for community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 67s
Year: 2005

Biomarkers and clinical stability in community-acquired pneumonia
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009


The peculiarity of community-acquired pneumonia (CAP) express-diagnostic by means of bacterioscopy
Source: Eur Respir J 2004; 24: Suppl. 48, 413s
Year: 2004

Mixed community-acquired pneumonia in hospitalised patients
Source: Eur Respir J 2006; 27: 795-800
Year: 2006



Update on community-acquired pneumonia
Source: International Congress 2017 – ME5 Update on community-acquired pneumonia
Year: 2017


Severe community-acquired pneumonia
Source: Eur Respir Monogr 2016; 74: 101-116
Year: 2016